Page last updated: 2024-10-31

metoclopramide and Reperfusion Injury

metoclopramide has been researched along with Reperfusion Injury in 1 studies

Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.

Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Stiermaier, T1
Schaefer, P1
Meyer-Saraei, R1
Saad, M1
de Waha-Thiele, S1
Pöss, J1
Fuernau, G1
Graf, T1
Kurz, T1
Frydrychowicz, A1
Barkhausen, J1
Desch, S1
Thiele, H1
Eitel, I1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Impact of Morphine Treatment on Platelet Inhibition in Acute Myocardial Infarction[NCT02627950]Phase 4138 participants (Actual)Interventional2015-12-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for metoclopramide and Reperfusion Injury

ArticleYear
Impact of Morphine Treatment With and Without Metoclopramide Coadministration on Myocardial and Microvascular Injury in Acute Myocardial Infarction: Insights From the Randomized MonAMI Trial.
    Journal of the American Heart Association, 2021, 05-04, Volume: 10, Issue:9

    Topics: Aged; Analgesics, Opioid; Coronary Angiography; Coronary Circulation; Dopamine D2 Receptor Antagonis

2021